The uterus and placenta of the mouse and rat produce a member of the prolactin (PRL) family referred to as decidual/trophoblast PRL-related protein (d/tPRP). This cytokine/hormone has been hypothesized to regulate decidual cell activities needed for the establishment and maintenance of gestation. An alkaline phosphatase (AP)-tagging strategy was used to identify d/tPRP target cells. AP-d/tPRP bound to virtually all cells and tissues to which it was exposed, consistent with our earlier evidence that d/tPRP binds to heparin-containing molecules. Moreover, we found that co-incubation with heparin or pretreatment with heparitinase greatly decreased the binding of AP-d/tPRP to tissue sections. In addition, we observed that the AP-d/tPRP probe bound to the surface of Chinese hamster ovary (CHO) cells but not to heparan sulfate-deficient CHO-pgsD-677 cells. Potential unique non-heparin d/tPRP binding sites within mouse and rat uteroplacental tissues were identified by consecutively incubating sections with AP-d/tPRP followed by heparin. This strategy led to the identification of d/tPRP target cells associated with the uterus and the labyrinth zone of the chorioallantoic placenta. Within the uterus, d/tPRP specifically bound to eosinophils. d/tPRP-binding and eosinophil peroxidase activity were co-localized and showed similar patterns of distribution during the estrous cycle, pregnancy, and following hormonal manipulation. d/tPRP interactions with eosinophils were further demonstrated in the lung and intestine, with eosinophils isolated from the peritoneum, and in mice with generalized tissue eosinophilia. Collectively, these findings suggest that intercellular d/tPRP targeting is mediated through associations with heparin-containing molecules which help direct d/tPRP to specific interactions with eosinophils within the uterus and with the labyrinthine compartment of the chorioallantoic placenta.
Introduction
The establishment of pregnancy requires numerous concomitant maternal uterine changes, including those related to the vasculature and immune cells. Hemochorial placentation occurs in both primates and rodents, resulting in the establishment of a close connection between maternal and fetal tissues (Enders & Welsh 1993) . This close connection facilitates the exchange of nutrients and wastes at the expense of an increased risk of maternal immune system recognition of the genetically disparate embryo. Decidual and trophoblast cells, and their secretory products, likely provide the signaling system that coordinates the activities of the maternal uterine compartment.
Decidual cells arise from uterine stroma, forming intimate relationships with placental structures that facilitate the development of the embryo (DeFeo 1967 , Bell 1983 , Parr & Parr 1989 . Among the important functions of decidual cells are their hormone/cytokine producing capabilities. In the mouse and rat, decidual cell production of a hormone related to pituitary prolactin (PRL) is of particular interest. This hormone, referred to as decidual/trophoblast PRL-related protein (d/tPRP), has been implicated in directing early changes in the uteroplacental compartment required for the establishment of pregnancy , Rasmussen et al. 1996 . d/tPRP was originally isolated during a search for a putative decidual luteotropin . Although d/tPRP exhibits significant structural similarities to PRL, it does not interact with PRL receptors and thus its putative luteotropic actions are suspect (Rasmussen et al. 1996) . d/tPRP is predominantly expressed by decidual cells during the first half of pregnancy and subsequently by spongiotrophoblast and trophoblast giant cells of the chorioallantoic placenta during the second half of pregnancy , Gu et al. 1994 , Lin et al. 1997 , Orwig et al. 1997a Rasmussen et al. 1997) . Once secreted from its cellular source, d/tPRP readily associates with heparin-containing molecules and accumulates in the extracellular matrix (Rasmussen et al. 1996) . Thus, d/tPRP is strategically positioned to interact with various populations of cells traversing the uteroplacental compartment (i.e. endothelial, immune and trophoblast cells).
The purpose of this investigation was to specifically identify cellular targets for d/tPRP. We have utilized an alkaline phosphatase (AP) tagging strategy that has been effectively used for identifying targets for other members of the PRL family (Müller et al. , 1999 . We show that AP-d/tPRP binds specifically to cells within the uterus and in the developing chorioallantoic placenta, including infiltrating eosinophils.
Eosinophils contribute actively to inflammatory responses through their secretion of a variety of chemical mediators (Gleich et al. 1993 , Venge 1993 , Weller 1993 , Hirai et al. 1997 , Rothenberg 1998 , Giembycz & Lindsay 1999 . These cells are actively recruited to sites of allergic responses (Kay et al. 1997) , tumors (Tepper et al. 1992) and parasite infestation (Pearlman 1997) . Eosinophil dynamics are precisely controlled within the uterus by the hormonal milieu, and exhibit dramatic fluctuations during the reproductive cycle (Rytomaa 1960 , Bassett 1962 , Ross & Klebanoff 1966 , McMaster et al. 1992 , Jeziorska et al. 1995 . For example, estrogen stimulates the infiltration of eosinophils into the uterus, whereas uterine exposure to progesterone is associated with eosinophil exit and death (Bjersing & Borglin 1964 , King et al. 1981 , Tchernitchin 1983 , Lee et al. 1989 , Howe et al. 1990 ). The present study suggests that since d/tPRP specifically interacts with eosinophils, this cytokine is a candidate mediator of the anti-inflammatory actions of progesterone during gestation.
Materials and Methods

Reagents
Supplies for polyacrylamide gel electrophoresis were purchased from Bio-Rad (Hercules, CA, USA). All restriction enzymes, polymerases, and DNA ligase were purchased from New England Biolabs (Beverly, MA, USA). Transformation competent DH 5 bacterial cells, Pfu polymerase were acquired from Stratagene (La Jolla, CA, USA). DNA extraction kits were purchased from Qiagen (Chatsworth, CA, USA). 
Animals and tissue preparation
Holtzman rats and CD-1 mice were obtained from Harlan Sprague-Dawley (Indianapolis, IN, USA). The IL-5 transgenic mouse line (NJ-1638) was established and propagated as previously described (Lee et al. 1997b) . Timed pregnancies, pseudopregnancies and tissue dissections were performed as previously described (Soares et al. 1983 , Soares 1987 , Orwig et al. 1997b . The presence of a copulatory plug was designated day 1 of pregnancy. Deciduomal responses were induced in pseudopregnant mice by injection of 50 µl sesame oil per uterine horn on day 4 of pseudopregnancy (Orwig et al. 1997b) . In some experiments, prepubertal rats (day 20 postnatal) were subcutaneously injected daily for 3 days with estradiol valerate (100 µg/100 µl; Bristol-Myers Squibb, Princeton, NJ, USA) or vehicle (sesame oil). Twenty-four hours following the last injection, rats were killed, uterine tissues dissected, and frozen for subsequent analysis. In all experiments, at least three different tissue samples were examined from a minimum of three different animals. Protocols for the care and use of animals were approved by the University of Kansas Animal Care and Use Committee.
Cell culture
Human embryonic kidney (HEK) 293 cells were used as a host for the expression of the AP-d/tPRP fusion protein. HEK 293 cells were routinely maintained in minimum essential medium (MEM) supplemented with 20 mM HEPES, 100 units/ml penicillin, 100 µg/ml streptomycin and 10% fetal bovine serum (FBS). CHO cells, heparan sulfate-deficient CHO-pgsD-677 cells (Lidholt et al. 1992) , and d/tPRP-expressing CHO cells (Rasmussen et al. 1996) were maintained in Dulbecco's MEM/MCDB 302 culture medium containing 100 units/ml penicillin, 100 µg/ml streptomycin and 10% FBS. All cells were cultured in an atmosphere of 5% CO 2 -95% air at 37 C in a humidified incubator.
Generation and characterization of the AP-d/tPRP fusion protein
A fusion protein consisting of a modified human placental AP (PLAP) and rat d/tPRP was generated and used to monitor d/tPRP target cell interactions. Procedures for generating the fusion protein were similar to those previously reported for the generation of an AP-placental lactogen-I (AP-PL-I) fusion protein . A vector containing ampicillin and neomycin resistance genes and a secreted version of PLAP (SEAP; Berger et al. 1988 ) situated downstream of a CMV promoter (pCMV/SEAP) was commercially obtained (Tropix). A nucleotide region representing the mature rat d/tPRP protein was then amplified and ligated into the pCMV/SEAP vector. Ligation with the d/tPRP insert resulted in a CMV promoter driven vector containing the ligated cDNAs encoding a SEAP-d/tPRP fusion protein (AP-d/tPRP). DNA sequencing of the insert was performed to verify the accuracy of the PCR amplification. After linearization, the AP-d/tPRP construct was electroporated into HEK 293 cells. Following a 2-week selection with 500 µg/ml G418, single clones were isolated by limiting dilution and screened for secreted heat stable AP activity. An unmodified pCMV/SEAP vector (AP) was similarly transfected, selected and served as a negative control. After the cells reached confluency, the culture medium was changed to serum-free MEM+ HEPES, further conditioned for 72 h, collected and clarified by centrifugation, and stored at 20 C until used. AP activity was measured from conditioned medium via a colorimetric assay . Western blot analysis for d/tPRP was performed as previously described (Rasmussen et al. 1996) . AP-d/tPRP preparations were isolated from conditioned medium using immunoprecipitation with monoclonal antibodies to AP conjugated to agarose. PRL-like biological activities were assessed through the use of the rat Nb2 lymphoma cell proliferation assay (Tanaka et al. 1980 ) and through incubation with CHO cells transiently transfected with the long form of the rat PRL receptor (pECE/long, Ali et al. 1992 ).
Analysis of AP-d/tPRP binding to tissues and cells
Tissues were frozen in dry ice-cooled heptane and stored at 70 C until tissue sections (8-10 µm) were prepared with the aid of a cryostat. Sections were mounted onto glass slides, washed in a modified Hank's balanced salt solution (HBHA; containing 20 mM HEPES, 0·5 mg/ml BSA and 0·1% NaN 3 ) and incubated with AP, AP-d/ tPRP, or AP-d/tPRP+excess recombinant rat d/tPRP for 75 min. Recombinant rat d/tPRP was generated in CHO cells and purified as previously described (Rasmussen et al. 1996) . Following incubation, the sections were washed with HBHA supplemented with 0·1% Tween 20 and fixed for 2 min in 20 mM HEPES buffer containing acetone (60%) and formaldehyde (3%). The fixed sections were washed, heated at 65 C for 30 min to inactivate endogenous tissue AP activity, and then processed for detection of the heat stable AP activity associated with the fusion proteins . For in situ AP detection 5-bromo-4-chloroindoxyl phosphate substrate and Nitroblue Tetrazolium were used. In experiments designed to co-localize AP-d/tPRP-binding and F4/80-immunoreactive cells, AP-fusion protein binding was assessed with a mouse monoclonal antibody to human PLAP (clone 8B6) and FITC-labeled goat anti-mouse IgG antibodies. Distinction of AP-d/tPRP binding to heparincontaining molecules from other potential interactions was achieved by treating tissue sections with heparin (250 µg/ml to 10 mg/ml) for 5 min following the HBHA and 0·1% Tween 20 washes. AP-d/tPRP binding to tissue sections was also evaluated following preincubation with heparitinase (5 units/ml) at 37 C for 1 h. The specificity of binding was further assessed by incubation with the AP control or by the addition of recombinant d/tPRP. AP-d/tPRP binding was also evaluated in various leukocytic cell populations (including eosinophils and macrophages) isolated from the rat peritoneum. Finally, AP-d/tPRP binding was assessed in CHO cells transiently transfected with an expression vector containing the long form of the rat PRL receptor (pECE/long, Ali et al. 1992) using FusGene 6 according to the manufacturer's instructions. The AP-PL-I fusion protein ) was used as a positive control for binding to the rat PRL receptor.
Isolation of rat peritoneal cells
Peritoneal serosal cells from rats were collected by lavage of the peritoneal cavity with MEM containing 15 mM HEPES, 10% FBS and heparin (50 µg/ml; HMEM) as previously described (Dileepan et al. 1993) . After gentle massage for 1 min, the peritoneal fluid was aspirated and the cells washed twice with HMEM. Macrophages and eosinophil fractions were isolated based on the procedure of MacKenzie et al. (1981) . Briefly, peritoneal cells were cultured for 2 h in 75 cm 2 plastic tissue culture flasks. Of the adherent cells >95% were macrophages. Nonadherent cells were collected, washed and resuspended in HMEM at a concentration of 10 7 cells/ml. Cells were further fractionated over a metrizamide gradient.
Metrizamide was made up to 18·5% and 22·5% (w/v) solution in HBSS (Hank's balanced salt solution). Two milliliters of the 22·5% metrizamide solution were overlaid with 2 ml of the 18·5% solution in a 15 ml centrifuge tube. One milliliter of the 1 10 7 cells/ml suspension of non-adherent cells was added and the tube centrifuged at room temperature for 15 min at 400 g. Eosinophils were collected at the 18·5%-22·5% metrizamide interface at a purity of 85-90%.
Immunocytochemical and histochemical analyses
d/tPRP protein expression was monitored by immunocytochemistry with antibodies to rat d/tPRP (Rasmussen et al. 1996) . Immunocytochemical identification of rat and mouse eosinophils utilized rabbit polyclonal antibodies to mouse and rat major basic protein respectively (Dembele-Duchesne et al. 1991 , Lee et al. 1997a . Eosinophils were histochemically identified by the presence of cyanide-resistant (8 mM NaCN) peroxidase activity as previously described (Horton et al. 1996) . For identification of cells of the mouse macrophages/ eosinophil lineage a rat monoclonal antibody referred to as F4/80 was used (Austyn & Gordon 1981 , McGarry & Stewart 1991 , whereas rat macrophages were identified with mouse monoclonal antibodies referred to as ED1 and ED2 (Dijkstra et al. 1985) . Immunocytochemistry was performed with streptavidin-biotin-immunoperoxidase kits using 3-amino-9-ethyl carbazole as a substrate. Control sections were incubated with non-immune serum or non-immune IgG.
Results
Generation and characterization of the AP-d/tPRP fusion protein
We generated and characterized an AP-d/tPRP fusion protein by in-frame insertion of the cDNA sequence of mature rat d/tPRP downstream from the SEAP coding sequence within the pCMV/SEAP vector (Tropix Inc.). The AP-d/tPRP construct and an unmodified AP control vector were transfected via electroporation into HEK 293 cells. The presence of AP activity in conditioned medium from transfected and non-transfected cells was evaluated using a colorimetric assay. Western blot analysis showed that d/tPRP antibodies recognized an AP-d/tPRP protein species approximating 110 kDa and native d/tPRP protein species of 29 kDa (Fig. 1) . The 110 kDa M r of the AP-d/tPRP fusion protein was consistent with the predicted M r of its AP and d/tPRP components. The AP-only control preparation was not recognized by the d/tPRP antibodies.
The AP-d/tPRP fusion protein was evaluated for its ability to interact with heparin-containing cells and the PRL receptor. The AP-d/tPRP fusion protein bound readily to heparan sulfate-containing wild-type CHO cells but not to heparan sulfate-deficient CHO-pgsD-677 cells (Fig. 2, top panel) . Moreover, AP-d/tPRP failed to bind heparan sulfate-deficient CHO cells transiently transfected with the long form of the rat PRL receptor (Fig. 2, bottom  panel) . In contrast, AP-PL-I, a known ligand of the PRL receptor, effectively bound to the PRL receptor transfected cells (Fig. 2, bottom panel) . Neither d/tPRP or the AP-d/tPRP fusion protein stimulated the proliferation of the PRL-responsive Nb2 lymphoma cells (data not shown). Collectively, these observations are consistent with earlier reports that d/tPRP interacts with heparincontaining molecules and does not activate the PRL receptor signaling pathway (Rasmussen et al. 1996) .
Identification of d/tPRP targets within the uterus
Heparin-dependent interactions AP-d/tPRP was used as a histo-specific marker to identify potential targets in mouse and rat uteroplacental tissues during various stages of gestation. The AP-d/tPRP probe bound to virtually all components of the uterus. This widespread interaction of AP-d/tPRP with uteroplacental compartments was shown to be dependent on heparin-containing molecules since pretreatment of tissue sections with heparitinase greatly decreased AP-d/tPRP binding (Fig. 3) as did preincubation of AP-d/tPRP with heparin (data not shown). A population of non-heparin binding sites was identified by consecutively incubating tissue sections with AP-d/tPRP followed by excess heparin (250 µg/ml to 10 mg/ml). This strategy led to the identification of discrete d/tPRP target cells within the endometrium and myometrium of the non-pregnant rat uterus (Fig. 4) . Specificity of the d/tPRP interaction with uterine cells was further demonstrated by use of an AP control probe, which showed no detectable binding to uterine tissue sections (Fig. 4) and by competition assays demonstrating that excess recombinant d/tPRP attenuated the binding of AP-d/tPRP to the uterine cells (Fig. 4) .
Distribution of d/tPRP binding within the uterus
The distribution of AP-d/tPRP target cells within mouse and rat uteri was similar to the distribution of leukocytes, especially macrophages and eosinophils within the uterus (Bassett 1962 , Ross & Klebanoff 1966 , Tachi & Tachi 1986 , Redline et al. 1989 , McMaster et al. 1992 , King et al. 1981 , Stewart & Mitchell 1991 , Yelavarthi et al. 1991 , Brandon 1993 , 1995 , Kaushic et al. 1998 . In order to clarify this relationship, d/tPRP binding was compared with the distribution of the F4/80 antigen (a macrophage/eosinophil marker; Austyn & Gordon 1981 , McGarry & Stewart 1991 and eosinophils via monitoring of eosinophil peroxidase histochemistry (King et al. 1981 , Horton et al. 1996 . In some cases, eosinophils were localized using immunocytochemistry for major basic protein-1, an eosinophil-specific granule protein (Dembele-Duchesne et al. 1991, Lee et al. 1997a) . While the distributions of d/tPRP binding and F4/80 immunoreactivity were only roughly similar, the locations of d/tPRP binding and eosinophils were virtually identical (Fig. 5) . d/tPRP binding cells were most abundant in non-pregnant and day 4 pseudopregnant mouse endometrium and myometrium ( Fig. 5A and E) . Following the decidual reaction, d/tPRP binding cells and eosinophils were rare within mouse decidua (Fig. 5I , J, M, N, Q and R). d/tPRP binding was reciprocally related to the distribution of decidual cells expressing d/tPRP. Decidual cell patterns of d/tPRP expression were similar to previous reports from our laboratory ( Fig. 5L and P ; Orwig et al. 1997a , Rasmussen et al. 1997 . During pregnancy in the mouse, F4/80 positive cells, d/tPRP binding cells and eosinophils were most prominent in interimplantation sites (Fig. 5Q, R and S) . Furthermore, the number of F4/80 positive cells (macrophages+eosinophils) always outnumbered d/tPRP binding cells, especially in tissues from pseudopregnant and pregnant mice. These observations were consistent with d/tPRP interacting with eosinophils and/or a subpopulation of macrophages. (Fig. 7) but not to macrophages isolated from the peritoneum (Fig. 7) . Collectively, the results are consistent with d/tPRP interacting with eosinophils.
Identification of eosinophils as d/tPRP targets
The overall capacity of d/tPRP binding to eosinophils present in the rat or mouse uterus (Figs 4 and 5) was consistently greater than observed for eosinophils isolated from the peritoneum (Fig. 7) or blood (data not shown). These observations prompted an investigation of d/tPRP binding to eosinophils present in other tissues. d/tPRP bound avidly to eosinophils present in the rat intestine and in the rat lung (Fig. 8) . Thus, d/tPRP binding is not unique to uterine eosinophils and appears to be enhanced by eosinophils situated within tissues.
The specific association of d/tPRP with tissue eosinophils was further demonstrated by examining AP-dPRP binding to tissues from normal and IL-5 transgenic mice (Lee et al. 1997b) . IL-5 transgenic mice exhibit a generalized tissue eosinophilia. Uteri and lungs from prepubertal normal mice exhibit limited numbers of eosinophils and d/tPRP binding cells (Fig. 9A and B, E and F), whereas these same tissues from IL-5 transgenic mice show extensive numbers of eosinophils and d/tPRP binding cells (Fig. 9C and D, G 
and H).
Estrogen control of uterine d/tPRP binding and eosinophil distributions Eosinophils exhibit dynamic changes within the uterus dependent upon the steroid hormone milieu. For example, estrogen stimulates the infiltration of eosinophils into the uterus (Bjersing & Borglin 1964 , King et al. 1981 , Tchernitchin 1983 , Lee et al. 1989 . This observation was confirmed by administration of exogenous estradiol (Fig. 10) . Cells binding d/tPRP and possessing eosinophil peroxidase dramatically increased in uteri from the estradiol-treated versus the vehicle-treated control rats.
Identification of d/tPRP targets within the chorioallantoic placenta
d/tPRP is characterized by its dual expression in decidual tissue from implantation until mid-gestation and in spongiotrophoblast and trophoblast giant cells of the chorioallantoic placenta from mid-gestation until the end of pregnancy (Orwig et al. 1997a,b; Rasmussen et al. 1997) . AP-d/tPRP binding was examined in mouse and rat uteroplacental tissues from mid-pregnancy to term. AP-d/tPRP bound specifically and prominently to the labyrinth zone of mouse (Fig. 11 ) and rat (data not shown) chorioallantoic placentas. d/tPRP binding appeared to increase as a function of gestational development.
Discussion
d/tPRP interactions with heparin-containing molecules
Heparin-containing molecules are prominently displayed on the external surfaces of cells and their extracellular matrices (Hassell et al. 1986 ). Several pieces of data are consistent with d/tPRP interactions with heparincontaining molecules: i) d/tPRP specifically binds to heparin Sepharose and is released from cultured cells by treatment with heparitinase (Rasmussen et al. 1996) ; ii) d/tPRP co-isolates with extracellular matrix proteins and is not detectable in maternal circulation (Rasmussen et al. 1996) ; iii) d/tPRP binds to wild-type heparan sulfatecontaining CHO cells but not to heparan sulfate-deficient CHO-pgsD-677 cells (present study); iv) d/tPRP binding to tissues is dramatically affected by pretreatment with heparitinase and/or heparin (present study). d/tPRPheparin interactions are likely relevant to the actions of d/tPRP on its targets. These ligand-heparin associations presumably facilitate the accumulation of d/tPRP in proximal locations and prevent d/tPRP from accessing systemic targets. d/tPRP interactions with heparin may also contribute conformationally to the biological Diffusion of d/tPRP away from its cellular sources within decidua versus the chorioallanotic placenta likely differ due to differences in the heparan sulfate composition of the two sites. Extracellular matrix of the decidua is richly endowed in heparan sulfate proteoglycans (Wewer et al. 1986) , whereas the junctional zone of the chorioallantoic placenta is conspicuously devoid of heparan sulfate proteoglycans (Laurie 1985) . This dichotomy in the environment surrounding the sites of d/tPRP synthesis presumably results in differential access to targets within these tissues. During the first half of pregnancy, d/tPRP diffusion is likely restricted to the decidual cells responsible for its synthesis and the associated extracellular matrix, whereas during the second half of gestation, d/tPRP is likely capable of diffusing to tissues bordering the junctional zone, i.e. decidual basalis and labyrinth zone of the chorioallantoic placenta.
d/tPRP interactions with eosinophils
Eosinophils are components of inflammatory responses that are likely to participate in immune surveillance against parasitic infections and solid tumors (Gleich et al. 1993 , Venge 1993 , Weller 1993 , Tepper et al. 1992 , Tepper 1994 , Hirai et al. 1997 , Rothenberg 1998 , Giembycz & Lindsay 1999 , LeMoine et al. 1999a . These cells are identified based on the composition of their granules which contain a variety of cytotoxic molecules that can cause considerable damage to surrounding normal cells (Gleich et al. 1993 , Venge 1993 , Weller 1993 , Hirai et al. 1997 , Rothenberg 1998 , Giembycz & Lindsay 1999 .
Eosinophils are normal, and relatively abundant, constituents of both rodent and human uterine endometria (Rytomaa 1960 , Bassett 1962 , Ross & Klebanoff 1966 , McMaster et al. 1992 , Jeziorska et al. 1995 . In rodents, the most dramatic changes in uterine eosinophil distributions occur prior to mating and during pregnancy. Eosinophils infiltrate into the uterine endometrium preceding mating and are effectively removed from the vicinity of the developing embryo accompanying the establishment of pregnancy (McMaster et al. 1992, present study) . It may be advantageous to have eosinophils present in the uterus around the time of mating when there is a possibility for the introduction of potential infectious agents. Likewise, it would also appear efficacious to remove or restrain the eosinophils once the pregnancy has been initiated in order to prevent their attack of the semi-allogeneic embryo. Mechanisms underlying this form of immunoprotection have not been well defined. Decidual tissue represents a barrier effectively excluding eosinophils (present study). Progesterone participates in the control of the development of decidual cells (DeFeo 1967 , Lydon et al. 1995 and possesses key anti-inflammatory actions within the uterus (Siiteri & Stites 1982 , Finn 1986 , Tibbetts et al. 1999 . d/tPRP likely contributes to the maternal adaptation to pregnancy and may mediate, at least in part, the anti-inflammatory actions of progesterone. Once secreted, d/tPRP is trapped in the decidual extracellular matrix where it associates with heparin-containing molecules and has access to migratory cells, including eosinophils (Rasmussen et al. 1996, present study) 
d/tPRP interactions with the labyrinthine placental compartment
As gestation progresses, d/tPRP is produced in the junctional zone of the chorioallantoic placenta (Rasmussen et al. 1997) , where it presumably diffuses to adjoining tissues due to the absence of heparan sulfate proteoglycan within the junctional zone (Laurie 1985) . This secreted d/tPRP may potentially target the underlying labyrinthine trophoblast and eosinophils in the decidual basalis (present study).
Overview d/tPRP is part of a larger family of regulatory molecules that help ensure viviparity. This family includes: PRL, which possesses specific modulatory actions on the maternal ovaries, liver, and mammary gland ; proliferin and proliferin-related protein, which influence development of vasculature within the uteroplacental compartment (Jackson et al. 1994) ; PRL-like protein-A, which specifically targets uterine natural killer cells (Müller et al. 1999) ; and PRL-like protein-E, which controls aspects of hematopoiesis (Lin & Linzer 1999) . The biology of other members of the uteroplacental PRL family are yet to be described.
The nature of d/tPRP's actions on eosinophils or the labyrinthine placenta is not known. d/tPRP does not interact with the PRL receptor (Rasmussen et al. 1996, present study) . Consequently, d/tPRP actions are likely mediated by alternative signaling pathways. It is not entirely clear whether specific and unique receptor signaling systems have co-evolved with each PRL family member, whether PRL family members utilize signaling pathways for other known ligands, or whether PRL family members act through receptor-independent mechanisms (e.g. transport proteins, binding proteins, etc.).
In summary, using an AP tagging strategy, d/tPRP is shown to specifically interact with eosinophils and the labyrinthine placenta. We propose that d/tPRP participates in the regulation of uterine eosinophils and the labyrinthine placenta in ways that contribute to the establishment and maintenance of pregnancy.
